Adial Pharmaceuticals Inc (NASDAQ:ADIL) price closed higher on Monday, April 15, jumping 12.02% above its previous close.
A look at the daily price movement shows that the last close reads $2.33. The company’s 5Y monthly beta was ticking 1.53. Taking into account the 52-week price action we note that the stock hit a 52-week high of $14.00 and 52-week low of $0.76. The stock added 50.00% on its value in the past month.
Adial Pharmaceuticals Inc, which has a market valuation of $10.57 million, is expected to release its quarterly earnings report May 10, 2024 – May 14, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ADIL a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as Hold.
The overview shows that ADIL’s price is at present 66.00% off the SMA20 and 69.83% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 64.22, with weekly volatility standing at 31.95%. The indicator jumps to 18.40% when calculated based on the past 30 days. Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s beta value is holding at 1.35, while the average true range (ATR) indicator is currently reading 0.44.
An analysis of the Adial Pharmaceuticals Inc (NASDAQ:ADIL) stock in terms of its daily trading volume indicates that the 3-month average is 6.38 million.
Current records show that the company has 4.05M in outstanding shares. The insiders’ percentage holdings are 9.50% of outstanding shares while the percentage share held by institutions stands at 6.55%. But the 40.32% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
